Zdrowie i gospodarka · 07/10/1997
FDA Releases Guidance on Reducing BSE Risk in Gelatin for Human Use
The FDA has published a guidance document to help industry reduce the risk of Bovine Spongiform Encephalopathy (BSE) transmission in gelatin used in FDA-regulated products for human consumption
Source: Federal Register — Food and Drug AdministrationOpen original release →